Forian Inc. (NASDAQ:FORA) CEO Max C. Wygod Buys 12,320 Shares

Forian Inc. (NASDAQ:FORAGet Free Report) CEO Max C. Wygod acquired 12,320 shares of the stock in a transaction dated Tuesday, February 11th. The stock was acquired at an average cost of $2.67 per share, with a total value of $32,894.40. Following the transaction, the chief executive officer now owns 1,324,500 shares of the company’s stock, valued at approximately $3,536,415. This trade represents a 0.94 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Forian Stock Up 10.0 %

Shares of NASDAQ:FORA opened at $2.76 on Friday. The business has a fifty day simple moving average of $2.16 and a 200-day simple moving average of $2.20. Forian Inc. has a 52 week low of $1.96 and a 52 week high of $4.15. The company has a market cap of $85.60 million, a P/E ratio of -30.67 and a beta of 1.06.

Institutional Investors Weigh In On Forian

A number of institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC grew its position in Forian by 48.9% during the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company’s stock valued at $73,000 after acquiring an additional 11,601 shares during the period. Virtu Financial LLC purchased a new stake in Forian during the fourth quarter valued at about $30,000. Elser Financial Planning Inc purchased a new stake in Forian during the fourth quarter valued at about $1,151,000. Finally, Canton Hathaway LLC grew its position in Forian by 2.3% during the third quarter. Canton Hathaway LLC now owns 269,650 shares of the company’s stock valued at $582,000 after acquiring an additional 6,125 shares during the period. Hedge funds and other institutional investors own 19.25% of the company’s stock.

Analysts Set New Price Targets

Separately, Roth Mkm reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Forian in a research report on Thursday, November 14th.

View Our Latest Research Report on FORA

Forian Company Profile

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Recommended Stories

Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.